[18F]F13640:一种用于人体功能性5-HT1A受体显像的选择性激动剂PET放射性药物
本研究在13名健康男性志愿者中开展PET/CT与PET-MRI扫描,评估选择性5-HT1A受体激动剂[18F]F13640的脑内标记特征并建立简化定量模型。结果显示中缝核与皮层区域高摄取,LREF模型在重测信度与可靠性方面表现更优,小脑白质与额叶白质可作为参考区域。
要点
- [18F]F13640在人体脑内中缝核与皮层区域呈高摄取。
- LREF模型与采用动脉输入函数的动力学模型高度相关,重测信度与可靠性更优。
- 小脑白质与额叶白质可作为[18F]F13640的合适参考区域。
核心结论
- [18F]F13640具有良好的脑内标记与动力学特征、高受体特异性及高效激动剂特性,为研究功能性活跃的5-HT1A受体提供新视角。
- 其动力学特性允许在PET扫描仪外注射并延迟采集,便于在神经病学与精神病学中设计创新的纵向研究方案。
研究设计与样本
- 在13名健康男性志愿者(29±9岁)中开展PET/CT与PET-MRI扫描,其中9名行动脉输入函数(AIF)测定,8名进行重测方案。
- 比较了单组织隔室模型、双组织隔室模型与Logan模型,并评估了简化参考组织模型(SRTM)与Logan参考模型(LREF)。
主要发现
- [18F]F13640在中缝核与皮层区域显示高摄取值。
- SRTM与LREF模型与采用AIF的动力学模型呈很高相关性。
- 就重测参数与[18F]F13640延长的结合动力学而言,LREF方法的重测信度与可靠性更优。
- 小脑白质与额叶白质可作为合适的参考区域。
关键数值与推荐
- SRTM与LREF模型与采用AIF的动力学模型呈很高相关性。
- LREF方法在重测信度与可靠性方面优于其他方法。
- 小脑白质与额叶白质被确定为合适参考区域。
临床怎么用
- [18F]F13640的动力学特性允许在PET扫描仪外注射并延迟采集,便于设计神经病学与精神病学的纵向研究方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: F13640 (a.k.a. befiradol, NLX-112) is a highly selective 5-HT1A receptor ligand that was selected as a PET radiopharmaceutical-candidate based on animal studies. Due to its high efficacy agonist properties, [18F]F13640 binds preferentially to functional 5-HT1A receptors, which are coupled to intracellular G-proteins. Here, we characterize brain labeling of 5-HT1A receptors by [18F]F13640 in humans and describe a simplified model for its quantification. METHODS: PET/CT and PET-MRI scans were conducted in a total of 13 healthy male volunteers (29 ± 9 years old), with arterial input functions (AIF) (n = 9) and test-retest protocol (n = 8). Several kinetic models were compared (one tissue compartment model, two-tissue compartment model, and Logan); two models with reference region were also evaluated: simplified reference tissue model (SRTM) and the logan reference model (LREF). RESULTS: [18F]F13640 showed high uptake values in raphe nuclei and cortical regions. SRTM and LREF models showed a very high correlation with kinetic models using AIF. As concerns test-retest parameters and the prolonged binding kinetics of [18F]F13640, better reproducibility, and reliability were found with the LREF method. Cerebellum white matter and frontal lobe white matter stand out as suitable reference regions. CONCLUSION: The favorable brain labeling and kinetic profile of [18F]F13640, its high receptor specificity and its high efficacy agonist properties open new perspectives for studying functionally active 5-HT1A receptors, unlike previous radiopharmaceuticals that act as antagonists. [18F]F13640's kinetic properties allow injection outside of the PET scanner with delayed acquisitions, facilitating the design of innovative longitudinal protocols in neurology and psychiatry. TRIAL REGISTRATION: Trial Registration EudraCT 2017-002,722-21.
引用
- Courault P, Lancelot S, Costes N, et al. [18F]F13640: a selective agonist PET radiopharmaceutical for imaging functional 5-HT1A receptors in humans. Eur J Nucl Med Mol Imaging. 2023. PMID: 36656363. doi:10.1007/s00259-022-06103-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。